Europe Genetic Testing Market (2019-2025)
The Europe Genetic Testing Market would witness market growth of 10.8% CAGR during the forecast period (2019-2025).
In the past couple of decades, the market for genetic testing has witnessed rapid development. The growing technological developments have opened up several market expansion possibilities. The rise in chronic disease prevalence and the creation of customized test kits for niche therapeutic fields contribute to the accelerated market growth.
A wide variety of advantages provided by genetic testing, including an understanding of genetic changes in the fetus that may lead to unusual growth and improved knowledge of genetic diseases and disorders, contribute significantly to the growth of the market for genetic testing during the forecast period. Growing understanding of such conditions and disorders has led more individuals to go and test themselves and their family members to gain a stronger awareness of their genetic structure. This has resulted in a growing audience for genetic testing, expanding the market's growth chart to new stages. In addition, changes in food habits, pollution, and exposure to damaging chemicals radiation contribute to rising genetic disease incidence, accelerating the industry exponentially.
Based on Type, the market is segmented into Predictive and Presymptomatic Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Other Types. Based on Technology, the market is segmented into Cytogenetic Testing, Biochemical Testing and Molecular Testing. Based on Application, the market is segmented into Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).
Scope of the Study
Market Segmentation:
By Type
In the past couple of decades, the market for genetic testing has witnessed rapid development. The growing technological developments have opened up several market expansion possibilities. The rise in chronic disease prevalence and the creation of customized test kits for niche therapeutic fields contribute to the accelerated market growth.
A wide variety of advantages provided by genetic testing, including an understanding of genetic changes in the fetus that may lead to unusual growth and improved knowledge of genetic diseases and disorders, contribute significantly to the growth of the market for genetic testing during the forecast period. Growing understanding of such conditions and disorders has led more individuals to go and test themselves and their family members to gain a stronger awareness of their genetic structure. This has resulted in a growing audience for genetic testing, expanding the market's growth chart to new stages. In addition, changes in food habits, pollution, and exposure to damaging chemicals radiation contribute to rising genetic disease incidence, accelerating the industry exponentially.
Based on Type, the market is segmented into Predictive and Presymptomatic Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Other Types. Based on Technology, the market is segmented into Cytogenetic Testing, Biochemical Testing and Molecular Testing. Based on Application, the market is segmented into Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).
Scope of the Study
Market Segmentation:
By Type
- Predictive and Presymptomatic Carrier Testing
- Prenatal and Newborn Testing
- Diagnostic Testing
- Pharmacogenomic Testing
- Other Types
- Cytogenetic Testing
- Biochemical Testing and
- Molecular Testing
- Cancer Diagnosis
- Genetic Disease Diagnosis
- Cardiovascular Disease Diagnosis and
- Other Applications
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Myriad Genetics, Inc.
- Empire Genomics LLC
- Bio-Rad Laboratories, Inc.
- Novartis AG
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Illumina, Inc.
- Danaher Corporation
- Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Genetic Testing Market, by Type
1.4.2 Europe Genetic Testing Market, by Technology
1.4.3 Europe Genetic Testing Market, by Application
1.4.4 Europe Genetic Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE GENETIC TESTING MARKET BY TYPE
3.1 Europe Predictive and Presymptomatic Testing Market by Country
3.2 Europe Carrier Testing Market by Country
3.3 Europe Prenatal and Newborn Testing Market by Country
3.4 Europe Diagnostic Testing Market by Country
3.5 Europe Pharmacogenomic Testing Market by Country
3.6 Europe Other Types Genetic Testing Market by Country
CHAPTER 4. EUROPE GENETIC TESTING MARKET BY TECHNOLOGY
4.1 Europe Cytogenetic Testing Market by Country
4.2 Europe Biochemical Testing Market by Country
4.3 Europe Molecular Testing Market by Country
CHAPTER 5. EUROPE GENETIC TESTING MARKET BY APPLICATION
5.1 Europe Cancer Diagnosis Market by Country
5.2 Europe Genetic Disease Diagnosis Market by Country
5.3 Europe Cardiovascular Disease Diagnosis Market by Country
5.4 Europe Other Applications Market by Country
CHAPTER 6. EUROPE GENETIC TESTING MARKET BY COUNTRY
6.1 Germany Genetic Testing Market
6.1.1 Germany Genetic Testing Market by Type
6.1.2 Germany Genetic Testing Market by Technology
6.1.3 Germany Genetic Testing Market by Application
6.2 UK Genetic Testing Market
6.2.1 UK Genetic Testing Market by Type
6.2.2 UK Genetic Testing Market by Technology
6.2.3 UK Genetic Testing Market by Application
6.3 France Genetic Testing Market
6.3.1 France Genetic Testing Market by Type
6.3.2 France Genetic Testing Market by Technology
6.3.3 France Genetic Testing Market by Application
6.4 Russia Genetic Testing Market
6.4.1 Russia Genetic Testing Market by Type
6.4.2 Russia Genetic Testing Market by Technology
6.4.3 Russia Genetic Testing Market by Application
6.5 Spain Genetic Testing Market
6.5.1 Spain Genetic Testing Market by Type
6.5.2 Spain Genetic Testing Market by Technology
6.5.3 Spain Genetic Testing Market by Application
6.6 Italy Genetic Testing Market
6.6.1 Italy Genetic Testing Market by Type
6.6.2 Italy Genetic Testing Market by Technology
6.6.3 Italy Genetic Testing Market by Application
6.7 Rest of Europe Genetic Testing Market
6.7.1 Rest of Europe Genetic Testing Market by Type
6.7.2 Rest of Europe Genetic Testing Market by Technology
6.7.3 Rest of Europe Genetic Testing Market by Application
CHAPTER 7. COMPANY PROFILES
7.1 Myriad Genetics, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches:
7.1.5.2 Collaborations, Partnerships and agreements:
7.2 Empire Genomics LLC
7.2.1 Company Overview
7.3 Bio-Rad laboratories, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Collaborations, partnerships and agreements:
7.3.4.2 Product launches:
7.3.4.3 Acquisition and mergers:
7.3.5 Research & Development Expenses
7.4 Novartis AG
7.4.1 Company Overview
7.4.1 Financial Analysis
7.4.2 Segmental and Regional Analysis
7.4.3 Research & Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Collaborations, partnerships and agreements:
7.5 Agilent Technologies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product launches:
7.5.5.2 Expansions:
7.6 Thermo Fischer Scientific, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Qiagen N.V.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product launches:
7.7.5.2 Collaborations, partnerships and agreements:
7.8 Illumina, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Product launches:
7.9 Danaher Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and mergers:
7.1 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Collaborations, partnerships and agreements:
7.10.5.2 Product launches:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Genetic Testing Market, by Type
1.4.2 Europe Genetic Testing Market, by Technology
1.4.3 Europe Genetic Testing Market, by Application
1.4.4 Europe Genetic Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE GENETIC TESTING MARKET BY TYPE
3.1 Europe Predictive and Presymptomatic Testing Market by Country
3.2 Europe Carrier Testing Market by Country
3.3 Europe Prenatal and Newborn Testing Market by Country
3.4 Europe Diagnostic Testing Market by Country
3.5 Europe Pharmacogenomic Testing Market by Country
3.6 Europe Other Types Genetic Testing Market by Country
CHAPTER 4. EUROPE GENETIC TESTING MARKET BY TECHNOLOGY
4.1 Europe Cytogenetic Testing Market by Country
4.2 Europe Biochemical Testing Market by Country
4.3 Europe Molecular Testing Market by Country
CHAPTER 5. EUROPE GENETIC TESTING MARKET BY APPLICATION
5.1 Europe Cancer Diagnosis Market by Country
5.2 Europe Genetic Disease Diagnosis Market by Country
5.3 Europe Cardiovascular Disease Diagnosis Market by Country
5.4 Europe Other Applications Market by Country
CHAPTER 6. EUROPE GENETIC TESTING MARKET BY COUNTRY
6.1 Germany Genetic Testing Market
6.1.1 Germany Genetic Testing Market by Type
6.1.2 Germany Genetic Testing Market by Technology
6.1.3 Germany Genetic Testing Market by Application
6.2 UK Genetic Testing Market
6.2.1 UK Genetic Testing Market by Type
6.2.2 UK Genetic Testing Market by Technology
6.2.3 UK Genetic Testing Market by Application
6.3 France Genetic Testing Market
6.3.1 France Genetic Testing Market by Type
6.3.2 France Genetic Testing Market by Technology
6.3.3 France Genetic Testing Market by Application
6.4 Russia Genetic Testing Market
6.4.1 Russia Genetic Testing Market by Type
6.4.2 Russia Genetic Testing Market by Technology
6.4.3 Russia Genetic Testing Market by Application
6.5 Spain Genetic Testing Market
6.5.1 Spain Genetic Testing Market by Type
6.5.2 Spain Genetic Testing Market by Technology
6.5.3 Spain Genetic Testing Market by Application
6.6 Italy Genetic Testing Market
6.6.1 Italy Genetic Testing Market by Type
6.6.2 Italy Genetic Testing Market by Technology
6.6.3 Italy Genetic Testing Market by Application
6.7 Rest of Europe Genetic Testing Market
6.7.1 Rest of Europe Genetic Testing Market by Type
6.7.2 Rest of Europe Genetic Testing Market by Technology
6.7.3 Rest of Europe Genetic Testing Market by Application
CHAPTER 7. COMPANY PROFILES
7.1 Myriad Genetics, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches:
7.1.5.2 Collaborations, Partnerships and agreements:
7.2 Empire Genomics LLC
7.2.1 Company Overview
7.3 Bio-Rad laboratories, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Collaborations, partnerships and agreements:
7.3.4.2 Product launches:
7.3.4.3 Acquisition and mergers:
7.3.5 Research & Development Expenses
7.4 Novartis AG
7.4.1 Company Overview
7.4.1 Financial Analysis
7.4.2 Segmental and Regional Analysis
7.4.3 Research & Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Collaborations, partnerships and agreements:
7.5 Agilent Technologies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product launches:
7.5.5.2 Expansions:
7.6 Thermo Fischer Scientific, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Qiagen N.V.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product launches:
7.7.5.2 Collaborations, partnerships and agreements:
7.8 Illumina, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Product launches:
7.9 Danaher Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and mergers:
7.1 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Collaborations, partnerships and agreements:
7.10.5.2 Product launches:
LIST OF TABLES
TABLE 1 EUROPE GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 EUROPE GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 EUROPE PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE CARRIER TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE CARRIER TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE DIAGNOSTIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE DIAGNOSTIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 19 EUROPE CYTOGENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE CYTOGENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE BIOCHEMICAL TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE BIOCHEMICAL TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE MOLECULAR TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE MOLECULAR TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 26 EUROPE GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 27 EUROPE CANCER DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE CANCER DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 EUROPE GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 EUROPE GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 GERMANY GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 GERMANY GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 GERMANY GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 GERMANY GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 GERMANY GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 42 GERMANY GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 43 GERMANY GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 GERMANY GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 UK GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 UK GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 UK GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 UK GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 UK GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 50 UK GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 51 UK GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 52 UK GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 53 FRANCE GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 FRANCE GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 FRANCE GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 FRANCE GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 FRANCE GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 58 FRANCE GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 59 FRANCE GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 60 FRANCE GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 61 RUSSIA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 RUSSIA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 RUSSIA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 66 RUSSIA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 69 SPAIN GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 70 SPAIN GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 71 SPAIN GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SPAIN GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SPAIN GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 74 SPAIN GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 75 SPAIN GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 76 SPAIN GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 77 ITALY GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 78 ITALY GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 79 ITALY GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 ITALY GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 ITALY GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 82 ITALY GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 83 ITALY GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 84 ITALY GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 85 REST OF EUROPE GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF EUROPE GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF EUROPE GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF EUROPE GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 90 REST OF EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 91 REST OF EUROPE GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 92 REST OF EUROPE GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – MYRIAD GENETICS, INC.
TABLE 94 KEY INFORMATION – EMPIRE GENOMICS LLC
TABLE 95 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 96 KEY INFORMATION – NOVARTIS AG
TABLE 97 KEY INFORMATION – AGILENT TECHNOLOGIES, INC.
TABLE 98 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 99 KEY INFORMATION – QIAGEN N.V.
TABLE 100 KEY INFORMATION – ILLUMINA, INC.
TABLE 101 KEY INFORMATION – DANAHER CORPORATION
TABLE 102 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 1 EUROPE GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 EUROPE GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 EUROPE PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE CARRIER TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE CARRIER TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE DIAGNOSTIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE DIAGNOSTIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 19 EUROPE CYTOGENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE CYTOGENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE BIOCHEMICAL TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE BIOCHEMICAL TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE MOLECULAR TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE MOLECULAR TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 26 EUROPE GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 27 EUROPE CANCER DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE CANCER DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 EUROPE GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 EUROPE GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 GERMANY GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 GERMANY GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 GERMANY GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 GERMANY GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 GERMANY GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 42 GERMANY GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 43 GERMANY GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 GERMANY GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 UK GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 UK GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 UK GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 UK GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 UK GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 50 UK GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 51 UK GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 52 UK GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 53 FRANCE GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 FRANCE GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 FRANCE GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 FRANCE GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 FRANCE GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 58 FRANCE GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 59 FRANCE GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 60 FRANCE GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 61 RUSSIA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 RUSSIA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 RUSSIA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 66 RUSSIA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 69 SPAIN GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 70 SPAIN GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 71 SPAIN GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SPAIN GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SPAIN GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 74 SPAIN GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 75 SPAIN GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 76 SPAIN GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 77 ITALY GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 78 ITALY GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 79 ITALY GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 ITALY GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 ITALY GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 82 ITALY GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 83 ITALY GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 84 ITALY GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 85 REST OF EUROPE GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF EUROPE GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF EUROPE GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF EUROPE GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 90 REST OF EUROPE GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 91 REST OF EUROPE GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 92 REST OF EUROPE GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – MYRIAD GENETICS, INC.
TABLE 94 KEY INFORMATION – EMPIRE GENOMICS LLC
TABLE 95 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 96 KEY INFORMATION – NOVARTIS AG
TABLE 97 KEY INFORMATION – AGILENT TECHNOLOGIES, INC.
TABLE 98 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 99 KEY INFORMATION – QIAGEN N.V.
TABLE 100 KEY INFORMATION – ILLUMINA, INC.
TABLE 101 KEY INFORMATION – DANAHER CORPORATION
TABLE 102 KEY INFORMATION – ABBOTT LABORATORIES
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
